Production (Stage)
Citius Pharmaceuticals, Inc.
CTXR
$0.703
-$0.021-2.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.40K | 1.10M | 3.25M | 17.91M | 12.56M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 15.34M | 14.38M | 8.27M | -- | -- |
| Prepaid Expenses | 3.01M | 2.85M | 2.70M | 10.09M | 9.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.37M | 18.33M | 14.22M | 28.01M | 21.57M |
|
|
|||||
| Total Current Assets | 18.37M | 18.33M | 14.22M | 28.01M | 21.57M |
| Net Property, Plant & Equipment | 922.10K | 191.40K | 246.20K | 299.90K | 352.80K |
| Long-term Investments | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Goodwill | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Total Other Intangibles | 92.80M | 92.80M | 92.80M | 59.40M | 59.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38.10K | 38.10K | 38.10K | 38.10K | 38.10K |
| Total Assets | 121.48M | 120.70M | 116.65M | 97.09M | 90.71M |
|
|
|||||
| Total Accounts Payable | 9.37M | 7.36M | 33.33M | 1.66M | 2.67M |
| Total Accrued Expenses | 11.96M | 8.84M | 2.25M | 2.25M | 1.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 145.10K | 204.60K | 241.50K | 235.60K | 229.70K |
| Total Finance Division Other Current Liabilities | 28.40M | 28.40M | -- | -- | -- |
| Total Other Current Liabilities | 28.40M | 28.40M | -- | -- | -- |
| Total Current Liabilities | 49.88M | 44.81M | 35.81M | 4.15M | 4.17M |
|
|
|||||
| Total Current Liabilities | 49.88M | 44.81M | 35.81M | 4.15M | 4.17M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 786.70K | -- | 21.30K | 84.40K | 145.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.24M | 6.98M | 6.71M | 6.57M | 6.43M |
| Total Liabilities | 57.91M | 51.78M | 42.55M | 10.81M | 10.74M |
|
|
|||||
| Common Stock & APIC | 282.71M | 276.55M | 271.45M | 276.26M | 259.37M |
| Retained Earnings | -222.06M | -211.14M | -201.37M | -190.58M | -180.01M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 60.66M | 65.41M | 70.08M | 85.68M | 79.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 60.66M | 65.41M | 70.08M | 85.68M | 79.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.92M | 3.51M | 4.02M | 600.40K | 600.40K |
| Total Equity | 63.58M | 68.92M | 74.10M | 86.28M | 79.97M |
|
|
|||||